1
|
Taizhanova D, Kalimbetova A, Bodaubay R, Toleuova A, Toiynbekova R, Beysenbekova Z, Visternichan O, Tauesheva Z, Kadyrova I, Babenko D, Akhmaltdinova L, Kolesnichenko S, Kolesnikova Y, Avdienko OV, Akilzhanova A, Gerotziafas GT. Genetic Predictors of the Development of Complications after Coronary Stenting. J Pers Med 2022; 13:jpm13010014. [PMID: 36675675 PMCID: PMC9863814 DOI: 10.3390/jpm13010014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Revised: 12/09/2022] [Accepted: 12/19/2022] [Indexed: 12/24/2022] Open
Abstract
Due to the fact that there are scientific discussions about the significance of gene polymorphisms in the risk of developing cardiovascular complications after a percutaneous coronary intervention, it is of interest to evaluate the genetic predictors of the development of cardiovascular events. This study is a molecular genetic study. Association with the genes of biomarkers for inflammation and immune response increases the risk of cardiovascular events: rs1234313 (TNFSF4): (A/G, OR-4.57 (2.35-8.87), p ≤ 0.0001), (A/G-A/A, OR-3.14 (1.75-5.63), p ≤ 0.0001), and (A/G, OR = 4.01 (2.19-7.36), p ≤ 0.0001); rs3184504 (SH2D3); ATXN2: (C/T, OR-2.53 (1.28-5.01), T/T, OR-2.99 (1.13-7.92), p = 0.017)), (C/T-T/T, OR-2.61 (1.35-5.07), p = 0.000), and (OR-1.89 (1.15-3.09), p = 0.009)). According to the lipid metabolism biomarker genes, rs2943634: (A/C OR-2.57 (1.18-5.62), p = 0.013); according to the endothelial biomarker genes, rs2713604: (DNAJB8-AS1; GATA2): (C/T, OR-4.27 (2.35-7.76), p ≤ 0.0001), (C/T-C/C, OR-4.13 (2.31-7.40), p ≤ 0.0001), (OR-4.05 (2.24-7.30), p ≤ 0.0001), and (C/T, OR-3.46 (1.99-6.00), p ≤ 0.0001). The regression analysis found that in the presence of the rs2943634 gene polymorphism, the risk of late cardiovascular events increases by 4.007 times with 95% CI (1.502:10.692), p = 0.006. The genes of biomarkers for the risk of cardiovascular events are rs1234313(TNFSF4), rs3184504 (SH2D3; ATXN2), rs2943634, and rs2713604 (DNAJB8-AS1; GATA2). The only predictor of the development of new cardiovascular events was rs2943634, which belongs to the group of lipid metabolism biomarkers.
Collapse
Affiliation(s)
- Dana Taizhanova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Akerke Kalimbetova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
- Correspondence:
| | - Roza Bodaubay
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Aliya Toleuova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Rakhima Toiynbekova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Zhazira Beysenbekova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Olga Visternichan
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Zauresh Tauesheva
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Irina Kadyrova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Dmitriy Babenko
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Lyudmila Akhmaltdinova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Svetlana Kolesnichenko
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Yevgeniya Kolesnikova
- Department of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Olga V. Avdienko
- Shared Resource Laboratory, Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan
| | - Ainur Akilzhanova
- National Laboratory Astana, Laboratory of Genomic and Personalized Medicine, Nazarbayev University, Astana 010000, Kazakhstan
| | - Grigorios T. Gerotziafas
- Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine, Institut National de la Santé et de la Recherche Médicale, INSERM U938 and Faculté de Médecine Pierre et Marie Curie (UPMC), Sorbonne Universities, 75006 Paris, France
| |
Collapse
|
2
|
Kolesnichenko SI, Kadyrova IA, Lavrinenko AV, Zhumadilova ZA, Avdienko OV, Vinogradskaya YV, Fominykh YA, Panibratec LG, Akhmaltdinova LL. Mortality Risk Factors of Early Neonatal Sepsis During COVID-19 Pandemic. Infect Drug Resist 2022; 15:6307-6316. [PMID: 36337929 PMCID: PMC9635391 DOI: 10.2147/idr.s390723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Accepted: 10/22/2022] [Indexed: 11/05/2022] Open
Abstract
Purpose This study aimed to determine predisposing factors for negative outcome in infants with early neonatal sepsis during COVID-19. Patients and Methods A prospective cohort study of 172 newborns up to 4 days diagnosed with neonatal sepsis was carried out in Karaganda (Kazakhstan). The microbiological examination was used to identify a causative agent of bloodstream infection. ELISA was performed to determine the total anti-SARS-CoV-2 antibodies. Gestational age, mode of delivery, birth weight, C-reactive protein and procalcitonin levels, comorbidities, type of pathogen, duration of hospitalization and mother’s infection diseases were used for statistical analysis. Results Mortality in infants with neonatal sepsis was 22% (38/172). Anti-SARS-CoV-2 antibodies were detected in 68.3% of the newborns. Culture-negative ELBW infants have a 5.3-fold higher risk of death (p<0.001). Low gestational age and a shorter period of hospitalization were statistically associated with fatality. CRP is generally higher in deceased children (p=0.002). Necrotizing enterocolitis (p<0.001), pneumonia (p=0.009) and anemia (p=0.016) were significantly associated with negative outcome. And, 31.4% of the infants with sepsis had positive blood cultures. The leading cause of sepsis in newborns was CoNS – 57%. Conclusion During COVID-19 pandemic neonatal sepsis mortality was associated with low birth weight, gestational age, and comorbidities as in non-pandemic time. The relationship between COVID-19 in the mother and neonatal mortality was not found. However, anti-SARS-CoV-2 antibodies were detected in more than half of newborns.
Collapse
Affiliation(s)
- Svetlana I Kolesnichenko
- Shared Resource Laboratory, Research Centre, Karaganda Medical University, Karaganda, Kazakhstan,Correspondence: Svetlana I Kolesnichenko, Shared Resource Laboratory, Research Centre, Karaganda Medical University, 40 Gogol St, Karaganda, 100008, Kazakhstan, Tel +7 702 599 0225, Email
| | - Irina A Kadyrova
- Shared Resource Laboratory, Research Centre, Karaganda Medical University, Karaganda, Kazakhstan
| | - Alyona V Lavrinenko
- Shared Resource Laboratory, Research Centre, Karaganda Medical University, Karaganda, Kazakhstan
| | - Zhibek A Zhumadilova
- Shared Resource Laboratory, Research Centre, Karaganda Medical University, Karaganda, Kazakhstan
| | - Olga V Avdienko
- Shared Resource Laboratory, Research Centre, Karaganda Medical University, Karaganda, Kazakhstan
| | | | - Yevgeniy A Fominykh
- Regional Clinical Hospital of Karaganda, Perinatal Center No. 2, Karaganda, Kazakhstan
| | - Lyudmila G Panibratec
- Regional Clinical Hospital of Karaganda, Perinatal Center No. 2, Karaganda, Kazakhstan
| | - Lyudmila L Akhmaltdinova
- Shared Resource Laboratory, Research Centre, Karaganda Medical University, Karaganda, Kazakhstan,National Scientific Cardiac Surgery Center, Nur-Sultan, Kazakhstan
| |
Collapse
|